Location History:
- München, DE (2020)
- Oberursel, DE (2016 - 2021)
- Munich, DE (2021 - 2022)
Company Filing History:
Years Active: 2016-2025
Title: Martin Scholz: Innovator in Biopharmaceuticals
Introduction
Martin Scholz is a prominent inventor based in Oberursel, Germany. He has made significant contributions to the field of biopharmaceuticals, holding a total of 10 patents. His work focuses on developing innovative methods for producing viral vector-based compositions and biopharmaceutical drug products.
Latest Patents
One of his latest patents is a method for obtaining efficient viral vector-based compositions for vaccination or gene therapy. This invention involves preparing viral vector-based particles with a specific particle size distribution, utilizing replication-deficient viral vectors and a carefully formulated solution of sugars and excipients. Another notable patent is for producing low viscous and highly concentrated biopharmaceutical drug products. This method includes a two-phase process that ensures the biomolecule of interest is processed in the presence of amino acids and sugars, resulting in a highly concentrated product.
Career Highlights
Martin Scholz is currently associated with Leukocare AG, a company known for its innovative approaches in biopharmaceutical development. His expertise in the field has led to advancements that enhance the efficacy and stability of drug formulations.
Collaborations
He collaborates with talented professionals such as Kristina Kemter and Jens Altrichter, contributing to a dynamic research environment that fosters innovation.
Conclusion
Martin Scholz's work exemplifies the intersection of innovation and biopharmaceutical development. His patents reflect a commitment to advancing healthcare through scientific research and practical applications.